Cargando…
Neuroprotection by eIF2α-CHOP inhibition and XBP-1 activation in EAE/optic neuritiss
No therapies exist to prevent neuronal deficits in multiple sclerosis (MS), because the molecular mechanism responsible for the progressive neurodegeneration is unknown. We previously showed that axon injury-induced neuronal endoplasmic reticulum (ER) stress plays an important role in retinal gangli...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5550873/ https://www.ncbi.nlm.nih.gov/pubmed/28726788 http://dx.doi.org/10.1038/cddis.2017.329 |
_version_ | 1783256203186405376 |
---|---|
author | Huang, Haoliang Miao, Linqing Liang, Feisi Liu, Xiaodong Xu, Lin Teng, Xiuyin Wang, Qizhao Ridder, William H Shindler, Kenneth S Sun, Yang Hu, Yang |
author_facet | Huang, Haoliang Miao, Linqing Liang, Feisi Liu, Xiaodong Xu, Lin Teng, Xiuyin Wang, Qizhao Ridder, William H Shindler, Kenneth S Sun, Yang Hu, Yang |
author_sort | Huang, Haoliang |
collection | PubMed |
description | No therapies exist to prevent neuronal deficits in multiple sclerosis (MS), because the molecular mechanism responsible for the progressive neurodegeneration is unknown. We previously showed that axon injury-induced neuronal endoplasmic reticulum (ER) stress plays an important role in retinal ganglion cell (RGC) death and optic nerve degeneration in traumatic and glaucomatous optic neuropathies. Optic neuritis, one of the most common clinical manifestations of MS, is readily modeled by experimental autoimmune encephalomyelitis (EAE) in mouse. Using this in vivo model, we now show that ER stress is induced early in EAE and that modulation of ER stress by inhibition of eIF2α-CHOP and activation of XBP-1 in RGC specifically, protects RGC somata and axons and preserves visual function. This finding adds to the evidence that ER stress is a general upstream mechanism for neurodegeneration and suggests that targeting ER stress molecules is a promising therapeutic strategy for neuroprotection in MS. |
format | Online Article Text |
id | pubmed-5550873 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-55508732017-08-14 Neuroprotection by eIF2α-CHOP inhibition and XBP-1 activation in EAE/optic neuritiss Huang, Haoliang Miao, Linqing Liang, Feisi Liu, Xiaodong Xu, Lin Teng, Xiuyin Wang, Qizhao Ridder, William H Shindler, Kenneth S Sun, Yang Hu, Yang Cell Death Dis Original Article No therapies exist to prevent neuronal deficits in multiple sclerosis (MS), because the molecular mechanism responsible for the progressive neurodegeneration is unknown. We previously showed that axon injury-induced neuronal endoplasmic reticulum (ER) stress plays an important role in retinal ganglion cell (RGC) death and optic nerve degeneration in traumatic and glaucomatous optic neuropathies. Optic neuritis, one of the most common clinical manifestations of MS, is readily modeled by experimental autoimmune encephalomyelitis (EAE) in mouse. Using this in vivo model, we now show that ER stress is induced early in EAE and that modulation of ER stress by inhibition of eIF2α-CHOP and activation of XBP-1 in RGC specifically, protects RGC somata and axons and preserves visual function. This finding adds to the evidence that ER stress is a general upstream mechanism for neurodegeneration and suggests that targeting ER stress molecules is a promising therapeutic strategy for neuroprotection in MS. Nature Publishing Group 2017-07 2017-07-20 /pmc/articles/PMC5550873/ /pubmed/28726788 http://dx.doi.org/10.1038/cddis.2017.329 Text en Copyright © 2017 The Author(s) http://creativecommons.org/licenses/by/4.0/ Cell Death and Disease is an open-access journal published by Nature Publishing Group. This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Original Article Huang, Haoliang Miao, Linqing Liang, Feisi Liu, Xiaodong Xu, Lin Teng, Xiuyin Wang, Qizhao Ridder, William H Shindler, Kenneth S Sun, Yang Hu, Yang Neuroprotection by eIF2α-CHOP inhibition and XBP-1 activation in EAE/optic neuritiss |
title | Neuroprotection by eIF2α-CHOP inhibition and XBP-1 activation in EAE/optic neuritiss |
title_full | Neuroprotection by eIF2α-CHOP inhibition and XBP-1 activation in EAE/optic neuritiss |
title_fullStr | Neuroprotection by eIF2α-CHOP inhibition and XBP-1 activation in EAE/optic neuritiss |
title_full_unstemmed | Neuroprotection by eIF2α-CHOP inhibition and XBP-1 activation in EAE/optic neuritiss |
title_short | Neuroprotection by eIF2α-CHOP inhibition and XBP-1 activation in EAE/optic neuritiss |
title_sort | neuroprotection by eif2α-chop inhibition and xbp-1 activation in eae/optic neuritiss |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5550873/ https://www.ncbi.nlm.nih.gov/pubmed/28726788 http://dx.doi.org/10.1038/cddis.2017.329 |
work_keys_str_mv | AT huanghaoliang neuroprotectionbyeif2achopinhibitionandxbp1activationineaeopticneuritiss AT miaolinqing neuroprotectionbyeif2achopinhibitionandxbp1activationineaeopticneuritiss AT liangfeisi neuroprotectionbyeif2achopinhibitionandxbp1activationineaeopticneuritiss AT liuxiaodong neuroprotectionbyeif2achopinhibitionandxbp1activationineaeopticneuritiss AT xulin neuroprotectionbyeif2achopinhibitionandxbp1activationineaeopticneuritiss AT tengxiuyin neuroprotectionbyeif2achopinhibitionandxbp1activationineaeopticneuritiss AT wangqizhao neuroprotectionbyeif2achopinhibitionandxbp1activationineaeopticneuritiss AT ridderwilliamh neuroprotectionbyeif2achopinhibitionandxbp1activationineaeopticneuritiss AT shindlerkenneths neuroprotectionbyeif2achopinhibitionandxbp1activationineaeopticneuritiss AT sunyang neuroprotectionbyeif2achopinhibitionandxbp1activationineaeopticneuritiss AT huyang neuroprotectionbyeif2achopinhibitionandxbp1activationineaeopticneuritiss |